RJA
SNCE

Raymond James & Associates’s Science 37 Holdings, Inc. Common Stock SNCE Stock Holding History

Raymond James & Associates’s Portfolio SNCE Stock Details SNCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-838
Closed -$209K – 4313
2021
Q4 		$209K Buy
+838
New +$186K ﹤0.01% 3671

Other funds holding SNCE

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
QI
Qualcomm Inc San Diego, California $32.1M AUM 5.35% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
PVI
Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return

Raymond James & Associates's SNCE Position: Q1 2022 in Review

Raymond James & Associates sold out of Science 37 Holdings, Inc. Common Stock (SNCE) in Q1 2022, closing a stake of 838 shares — an estimated $209K sold.

Raymond James & Associates first reported a position in SNCE in Q4 2021 and held it in 1 quarter. The position peaked at $209K in Q4 2021. 52 funds tracked by Wall St. Rank hold SNCE as of Q1 2022.

  • Raymond James & Associates reported no remaining Science 37 Holdings, Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
  • Raymond James & Associates sold 838 Science 37 Holdings, Inc. Common Stock shares in Q1 2022, an estimated $209K.
  • Raymond James & Associates first reported a position in Science 37 Holdings, Inc. Common Stock in Q4 2021 and held it in 1 quarter.
  • Raymond James & Associates's Science 37 Holdings, Inc. Common Stock position peaked at $209K in Q4 2021.
  • 52 funds tracked by Wall St. Rank held Science 37 Holdings, Inc. Common Stock as of Q1 2022.

Based on Raymond James & Associates's 13F filing for Q1 2022, filed 11 May 2022.